Oliver RT - Search Results

1

Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.

Oliver RT, Mason MD, Mead GM, von der Maase H, Rustin GJ, Joffe JK, de Wit R, Aass N, Graham JD, Coleman R, Kirk SJ, Stenning SP; MRC TE19 collaborators and the EORTC 30982 collaborators. Oliver RT, et al. Lancet. 2005 Jul 23-29;366(9482):293-300. doi: 10.1016/S0140-6736(05)66984-X. Lancet. 2005. PMID: 16039331 Free article. Clinical Trial.

2

Radiotherapy after chemotherapy for metastatic seminoma--a diminishing role. MRC Testicular Tumour Working Party.

Duchesne GM, Stenning SP, Aass N, Mead GM, Fosså SD, Oliver RT, Horwich A, Read G, Roberts IT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook PA. Duchesne GM, et al. Among authors: oliver rt. Eur J Cancer. 1997 May;33(6):829-35. doi: 10.1016/s0959-8049(97)00033-6. Eur J Cancer. 1997. PMID: 9291801

3

Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy.

Fosså SD, Oliver RT, Stenning SP, Horwich A, Wilkinson P, Read G, Mead GM, Roberts JT, Rustin G, Cullen MH, Kaye SB, Harland SJ, Cook P. Fosså SD, et al. Among authors: oliver rt. Eur J Cancer. 1997 Aug;33(9):1380-7. doi: 10.1016/s0959-8049(96)00425-x. Eur J Cancer. 1997. PMID: 9337678

4

A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.

Horwich A, Oliver RT, Wilkinson PM, Mead GM, Harland SJ, Cullen MH, Roberts JT, Fossa SD, Dearnaley DP, Lallemand E, Stenning SP; MRC Testicular Tumour Working Party. Horwich A, et al. Among authors: oliver rt. Br J Cancer. 2000 Dec;83(12):1623-9. doi: 10.1054/bjoc.2000.1498. Br J Cancer. 2000. PMID: 11104556 Free PMC article. Clinical Trial.

5

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Research and Treatment of Cancer Trial.

Horwich A, Sleijfer DT, Fosså SD, Kaye SB, Oliver RT, Cullen MH, Mead GM, de Wit R, de Mulder PH, Dearnaley DP, Cook PA, Sylvester RJ, Stenning SP. Horwich A, et al. Among authors: oliver rt. J Clin Oncol. 1997 May;15(5):1844-52. doi: 10.1200/JCO.1997.15.5.1844. J Clin Oncol. 1997. PMID: 9164194 Free article. Clinical Trial.

6

Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.

Fosså SD, Stenning SP, Gerl A, Horwich A, Clark PI, Wilkinson PM, Jones WG, Williams MV, Oliver RT, Newlands ES, Mead GM, Cullen MH, Kaye SB, Rustin GJ, Cook PA. Fosså SD, et al. Among authors: oliver rt. Br J Cancer. 1999 Jul;80(9):1392-9. doi: 10.1038/sj.bjc.6690534. Br J Cancer. 1999. PMID: 10424741 Free PMC article.

7

Evidence for a schedule-dependent deleterious interaction between paclitaxel, vinblastine and cisplatin (PVC) in the treatment of advanced transitional cell carcinoma.

Mulatero C, McClaren BR, Mason M, Oliver RT, Gallagher CJ. Mulatero C, et al. Among authors: oliver rt. Br J Cancer. 2000 Dec;83(12):1612-6. doi: 10.1054/bjoc.2000.1480. Br J Cancer. 2000. PMID: 11104554 Free PMC article. Clinical Trial.

8

Postchemotherapy residual masses in germ cell tumor patients: content, clinical features, and prognosis. Medical Research Council Testicular Tumour Working Party.

Stenning SP, Parkinson MC, Fisher C, Mead GM, Cook PA, Fossa SD, Horwich A, Jones WG, Newlands ES, Oliver RT, Stenwig AE, Wilkinson PM. Stenning SP, et al. Among authors: oliver rt. Cancer. 1998 Oct 1;83(7):1409-19. Cancer. 1998. PMID: 9762943

9

Secondary tumours following etoposide containing therapy for germ cell cancer.

Boshoff C, Begent RH, Oliver RT, Rustin GJ, Newlands ES, Andrews R, Skelton M, Holden L, Ong J. Boshoff C, et al. Among authors: oliver rt. Ann Oncol. 1995 Jan;6(1):35-40. doi: 10.1093/oxfordjournals.annonc.a059037. Ann Oncol. 1995. PMID: 7536027 Free article.

10

Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy?

Oliver RT, Edmonds PM, Ong JY, Ostrowski MJ, Jackson AW, Baille-Johnson H, Williams MV, Wiltshire CR, Mott T, Pratt WR, et al. Oliver RT, et al. Int J Radiat Oncol Biol Phys. 1994 Apr 30;29(1):3-8. doi: 10.1016/0360-3016(94)90219-4. Int J Radiat Oncol Biol Phys. 1994. PMID: 8175442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters